Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients
Authors:
- 1 October 2021
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (1) , 452-459
Abstract
Background and objectives Different treatment response scoring systems in treated MS patients exist. The objective was to assess the long-term predictive value of these systems in RRMS patients treated with self-injectable DMTs. Methods RRMS-treated patients underwent brain MRI before the onset of therapy and 12 months thereafter, and neurological assessments every 6 months. Clinical and demographic characteristics were collected at baseline. After the first year of treatment, several scoring systems [Rio score (RS), modified Rio score (MRS), MAGNIMS score (MS), and ROAD score (RoS)] were calculated. Cox-Regression and survival analyses were performed to identify scores predicting long-term disability. Results We included 319 RRMS patients. Survival analyses showed that patients with RS > 1 and RoS > 3 had a significant risk of reaching an EDSS of 4.0 and 6.0 The score with the best sensitivity (61%) was the RoS, while the MRS showed the best specificity (88%). The RS showed the best positive predictive value (42%) and the best accuracy (81%). Conclusions The combined measures integrated into different scores have an acceptable prognostic value for identifying patients with long-term disability. Thus, these data reinforce the concept of early treatment optimization to minimize the risk of long-term disability.Keywords
This publication has 34 references indexed in Scilit:
- Defining and scoring response to IFN-β in multiple sclerosisNature Reviews Neurology, 2013
- Predictors of long‐term outcome in multiple sclerosis patients treated with interferon betaAnnals of Neurology, 2013
- Monitoring long-term treatments in multiple sclerosisNature Reviews Neurology, 2010
- One‐year MRI scan predicts clinical response to interferon beta in multiple sclerosisEuropean Journal of Neurology, 2009
- Predicting responders to therapies for multiple sclerosisNature Reviews Neurology, 2009
- Measures in the first year of therapy predict the response to interferon β in MSMultiple Sclerosis Journal, 2009
- Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?Neurology, 2008
- Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) scoreJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patientsAnnals of Neurology, 2006
- Rating neurologic impairment in multiple sclerosisNeurology, 1983